Differential Diagnosis
The patient's symptoms of fan apathy, night sweats, unintentional weight loss, and a history of HIV infection, combined with the presence of diffuse large B cells and irregular nuclei on excisional biopsy of a lymph node, suggest a range of potential diagnoses. These can be categorized as follows:
Single Most Likely Diagnosis
- Diffuse Large B-Cell Lymphoma (DLBCL): This is the most common type of non-Hodgkin lymphoma and is known to be aggressive. The patient's HIV status increases the risk for DLBCL, and the symptoms along with the biopsy findings are consistent with this diagnosis.
Other Likely Diagnoses
- Other Non-Hodgkin Lymphomas (NHL): While DLBCL is the most common, other types of NHL, such as follicular lymphoma or mantle cell lymphoma, could also present similarly, especially in an immunocompromised patient.
- Hodgkin Lymphoma: Although less common than NHL in HIV-positive individuals, Hodgkin lymphoma can also present with systemic symptoms and lymphadenopathy.
Do Not Miss Diagnoses
- Tuberculosis (TB): Given the patient's HIV status, TB is a critical diagnosis not to miss, as it can cause similar systemic symptoms (night sweats, weight loss) and lymphadenopathy. TB can be particularly aggressive in immunocompromised individuals.
- Castleman Disease: This rare disorder can cause lymphadenopathy and systemic symptoms similar to lymphoma, especially in HIV-positive patients. It's crucial to distinguish it from lymphoma due to differences in treatment and prognosis.
Rare Diagnoses
- Primary Effusion Lymphoma (PEL): A rare and aggressive type of lymphoma that typically occurs in HIV-positive individuals, often presenting with serous effusions without significant lymphadenopathy. While less likely given the lymph node involvement, it remains a consideration in the differential diagnosis of lymphomas in HIV patients.
- Lymphomatoid Granulomatosis: A rare lymphoproliferative disorder that can mimic lymphoma, often associated with Epstein-Barr virus (EBV) infection, which is more common in immunocompromised patients. It typically involves the lungs but can affect other areas, including lymph nodes.